Help With Estrogen Patch Shortages
May 2026
High demand and shortages are leading to questions about estrogen patches for menopausal hormone therapy (MHT).
More patients are opting to use MHT after FDA’s decision to remove certain boxed warnings. Plus, transdermal meds are often preferred over oral options...since they’re associated with less risk of blood clots.
Keep in mind, most evidence for transdermal estrogen is with patches and based on observational studies. All forms of systemic estrogen seem similar in efficacy at reducing vasomotor symptoms.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote